Skip to main content

This job has expired

You will need to login before you can apply for a job.

Manager, Financial Reporting and Technical Accounting

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Mar 1, 2021

View more

Discipline
Administration, Accounting, Finance
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Genetown

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We want all of our people to go beyond what is possible. We aren't constrained by typical end rails, and we aren't out to just treat people. We're all in this for something more. We're driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

Intellia Therapeutics is seeking a highly skilled and motivated accounting professional who will be responsible for Intellia's financial reporting and technical accounting efforts. Reporting to the Director of financial reporting and technical accounting, the successful candidate will assume a key role working collaboratively across the Finance team and the Company to ensure: (i) compliance with Securities and Exchange Commission (SEC) filings; (ii) assessing and providing technical accounting insights for new contracts and providing insights to senior leadership; (iii) designing, implementing, and tracking of internal controls over financial reporting in accordance with the 2002 Sarbanes-Oxley (SOX) Act; and (iv) assisting with reviewing the Company's tax provision and related tax work. Additionally, this individual will possess strong collaboration skills to partner with internal stakeholders as well as external auditors and consultants.

Responsibilities:
  • Assist the team in preparing the Company's SEC reporting on Forms 10-Q, 10-K, 8-K, Proxy and other ad hoc filings, including preparation of financial statements, footnotes, auditable support and analysis
  • Assist with research and preparation of technical accounting treatment position papers
  • Review new contracts and assess for accounting consequences.
  • Monitor new accounting pronouncements and accounting policy developments and support implementation efforts including required disclosures and senior management education
  • Participate in the month-end close process and management reporting for assigned areas
  • Perform special ad-hoc projects as required
  • Perform ongoing SOX compliance requirements. Support and adhere to strong internal control policies and procedures, identifying areas for improvement
  • Liaise with external auditors. Support consolidated financial audits including preparation of PBC items
  • Assist in establishing and maintaining accounting policies, best practices and procedures
  • Other general finance, accounting and tax work as deemed necessary


Qualifications:
  • BA/BS degree in Accounting or Finance
  • CPA is required
  • Minimum of 4 - 6 years of audit and/or SEC/technical accounting experience
  • Strong technical accounting background and understanding of U.S. GAAP.
  • Strong analytical and problem-solving skills
  • Highly detail oriented, organized, self-motivated and committed to a high level of accuracy
  • Must have strong work ethic and be able to meet critical deadlines. Ability to multitask in a fast-paced environment
  • Strong interpersonal, written and verbal communications skills
  • Excellent team player who can work collaboratively with cross-functional teams
  • Proficiency in Word, Excel and PowerPoint required


EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert